Clinical outcomes of patients with HER2 -mutant advanced lung cancer: chemotherapies versus HER2 -directed therapies

Background:Lung cancer is now the leading cause of cancer mortality worldwide for both men and women. In non-small cell lung cancer (NSCLC), matching a specifically targeted drug to the identified ...